Skip to content

Occupational Health

What the Latest Research Reveals

Data last updated: 20 studies cited

How this page is produced

Generated by the ModernDoc Research Monitor from peer-reviewed literature. Every statistic is automatically checked against its cited source and screened for retractions before it is published. This page is AI-generated and has not yet been reviewed by a clinician β€” it is not medical advice. Read how we build and check these pages.

1.8-4M
Americans out of work due to Long COVID
β€” representing 1-2.4% of the U.S. labor force
Source: Bach K. Brookings Institution (2022). 0

KEY FINDINGS

Healthcare Worker Long COVID Risk
1.5-2x
95% CI: OR 1.5-2.0 vs general population
Source [12]
Return to Work (Long COVID)
38.7%
95% CI: vs 82.3% for resolved COVID at 12 months
Source [11]
Reduced Work Hours
50%
95% CI: fewer hours worked if employed after Long COVID
Source [11]
Annual Lost Wages (US)
$168B
95% CI: $168-170 billion annually
Source [9]

THE TIMELINE

Acute Phase

0-4 weeks

Mean sick leave 1-2 weeks (mild), 3-4 weeks (moderate)

Key Event
Unable to work

Work Resumption at 12 Months

Source: Occupational Medicine Cohort Studies

Cumulative Long COVID Risk with Reinfection

1 infection+36%
2 infections+2.14x
3+ infections+3.75x

β€œEach infection compounds organ damage and increases Long COVID probability”

THE HOPEFUL HORIZON

  • Vaccination reduces Long COVID risk by 50-60%[3]
  • Well-ventilated spaces reduce transmission by 70-80%[6]
  • N95 masking reduces personal transmission risk by 80-95%[6]
  • RECOVER Initiative has 8 active clinical trials with 13 potential treatments under study

SOURCES

  1. [1]Chen C, et al. Global Prevalence of Long COVID, Its Subtypes, and Risk Factors: An Updated Systematic Review and Meta-analysis. Open Forum Infectious Diseases. 2025;12(9):ofaf533. DOI (opens in new tab)
  2. [2]Bowe B, Xie Y, Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nature Medicine. 2022;28(11):2398-2405. DOI (opens in new tab)
  3. [3]Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nature Medicine. 2022;28(7):1461-1467. DOI (opens in new tab)
  4. [4]Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nature Medicine. 2022;28(3):583-590. DOI (opens in new tab)
  5. [5]Douaud G, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604(7907):697-707. DOI (opens in new tab)

See a problem with the Occupational Health research summary?

Send a source correction or freshness concern. We cannot provide personal medical advice through this site.

Report a correction

SHARE THIS INFORMATION

Share with someone who needs to know

Data last updated:

Medical review: AI-generated β€” pending clinician review

Sources cited: 20 peer-reviewed sources

Claim verification: 0/0 verified (NaN%)

About DOIs

This information is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider for medical decisions. Data is sourced from peer-reviewed publications and may be updated as new research emerges.